Indicated for: bleeding; coagulation disorders
Route of administration: injectable / infusion
Substance: carbazochrome salicylate (anticoagulant)
ATC: B02BX02 (Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Carbazochrome salicylate is a medication used to reduce capillary bleeding and stabilize blood vessel walls. It is commonly used in the treatment of minor hemorrhages, such as epistaxis (nosebleeds) or bleeding associated with capillary fragility.
This medication works by strengthening capillary walls and reducing their permeability, thereby preventing blood loss. It is available in tablet or injectable forms, depending on the severity of the condition being treated.
Carbazochrome salicylate is generally well-tolerated but should be used as directed by a doctor. It is important for patients to inform their doctor about any other medications they are taking to avoid interactions.
Side effects are rare but may include allergic reactions, nausea, or abdominal discomfort. In very rare cases, severe reactions such as difficulty breathing or swelling may occur. Patients should seek immediate medical attention if such symptoms arise.
Price
Copayment
Patient
47.89 RON
47.89 RON
0.00 RON